Review
Open access
Aug 2026
Molecular Optimization of Benzimidazole Scaffolds for Targeted Protein Kinase Inhibition in Oncology
A comprehensive overview is provided on the incorporation of the benzimidazole scaffold in FDA‐approved drugs, as well as in clinical trial candidates being developed as protein kinase inhibitors for cancer treatment.
H. Abdel-Mohsen
· ChemistrySelect · 0 citations